CTMX stock touches 52-week low at $0.76 amid market challenges
CytomX Therapeutics Inc . (NASDAQ:CTMX) stock has reached a new 52-week low, trading at $0.76, as the biopharmaceutical company faces a challenging market environment. Despite the recent decline, ...
Centrexion stock hits 52-week low at $0.79 amid market challenges
In a turbulent market environment, Centrexion Therapeutics Corp (CNTX) stock has touched a new 52-week low, with shares falling to $0.79. According to InvestingPro data, this represents a stark ...